Back to search
End-stage Liver Disease (ESLD)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which End-stage Liver Disease (ESLD) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which End-stage Liver Disease (ESLD) trials you may qualify forThe purpose of this study is to assess the safety and efficacy of RTX001 in patients with end-stage liver disease. This study is the first time RTX001, a macrop…
We propose a multi-center randomized trial to test the primary hypothesis that tranexamic acid is superior to placebo on blood loss in adult orthotopic liver tr…
Liver transplantation carries a substantial risk of bleeding, making precise haemostasis control essential, although assessing coagulation remains challenging.…
There is a rise in the prevalence of end-stage liver disease during the last decade. End-stage liver disease has become one of the leading causes of death in We…
Stem cells are non-terminal cells that can self renew and replicate through symmetric or asymmetric division, with the potential to differentiate into different…